Pharmaceuticals

Arcturus Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Arcellx is a specialist cell therapy developer focused on engineered cellular therapies for cancer, particularly multiple myeloma. Its lead program, anitocabtagene autoleucel, has become one of the most closely watched next-generation BCMA-directed CAR-T candidates.

Apellis Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

ANI Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

Amneal Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

Amicus Therapeutics is an established rare disease company focused on rare metabolic disorders, particularly Fabry disease and Pompe disease. The company has built its platform around precision therapy for genetically defined lysosomal storage and metabolic conditions.

Amgen remains one of the most important biotechnology firms globally and one of the defining companies in the history of the modern biotechnology industry. The company has evolved from a pioneer of recombinant biologics into a global biopharmaceutical organization with substantial commercial scale, manufacturing depth, and pipeline breadth.

Alnylam Pharmaceuticals is one of the most important rare disease biotechnology companies because it validated RNA interference as a therapeutic modality and built approved medicines for genetically or biologically defined diseases. Its platform is especially relevant to rare diseases where silencing a disease-causing gene can produce meaningful clinical benefit.

Almac Group is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Allogene Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier II Cell & Gene Therapy Developers 1 ranking category Overview

Ajinomoto Bio-Pharma Services is a CDMO providing development and manufacturing services across small molecule APIs, drug product, sterile manufacturing, high-potency compounds, and antibody-drug conjugates. The company operates as part of Ajinomoto Group and serves pharmaceutical and biotechnology sponsors globally.

Alkermes is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

AGC Biologics is a global biopharmaceutical CDMO providing development and manufacturing services across biologics and advanced modalities. Its services include protein expression biologics, plasmid DNA, mRNA, viral vectors, and genetically engineered cells.

Advanced Clinical is a clinical development services provider supporting pharmaceutical, biotechnology, and medical device sponsors through CRO services, functional service provider models, clinical staffing, biometrics, and trial execution support.

Adaptimmune Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Acadia Pharmaceuticals is a specialist developer in neurological and neuropsychiatric disorders, with relevance to rare disease through Rett syndrome and related central nervous system conditions. The company’s focus on serious neurological disorders gives it a differentiated position in orphan and specialty medicine.

AbbVie remains one of the world’s most important specialty pharmaceutical companies. Although it operates at large pharmaceutical scale, its business model is deeply aligned with specialty medicine, particularly immunology, hematologic oncology, neuroscience, and medical aesthetics.

Praxis Precision Medicines is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Polpharma Biologics is a specialist biologics development and manufacturing organization with capabilities in biosimilars, mammalian cell culture, process development, analytical services, and biologics manufacturing. The company has built a strong European biologics platform with relevance in both proprietary biosimilars and contract manufacturing.

Piramal Pharma Solutions is an integrated CDMO providing services across drug discovery support, process development, API manufacturing, drug product development, sterile manufacturing, high-potency APIs, and antibody-drug conjugates. The company serves global pharmaceutical and biotechnology sponsors through a multi-site international network.